€
63.74
Change
+0.34 +0.54%
Volume
Volume 2.63m
May 20, 2022, 6:30 p.m.
Quotes are delayed by 20 min
Previous close
€ 63.40
€ 63.74
Change
+0.34 +0.54%
Day low
Day high
€63.69
€64.55

52 week low
52 week high
€43.91
€67.99

Market cap
€62.62B
Average volume
4.01M
P/E ratio
28.44
Rev. per Employee
€465,610
EPS
2.24
Dividend
2.00
Div yield
3.14%
Ex dividend date
5/2/22
MarketWatch News on BAYN
-
A sticking point in China competition bill: what to do about fake products
- Victor Reklaitis
-
Monsanto pleads guilty to pesticide-related crimes in Hawaii
- Associated Press
-
Explosion at industrial park shakes German city
- Associated Press
-
U.S. investors are pouring money into European stock funds
- Steve Goldstein
-
Idaho farmers file antitrust lawsuit against big ag companies
- Associated Press
-
Novartis agrees to help make CureVac COVID-19 vaccine
- Ciara Linnane
-
European stocks advance for fourth session in a row
- Steve Goldstein
- Loading more headlines...
Other News on BAYN
-
New Treatment for Fibroids Without Surgery
- The Wall Street Journal Interactive Edition
-
Overheard: Monsanto’s Rivals Could Be Help for Syngenta
- The Wall Street Journal Interactive Edition
-
Bayer Reiterates Plans to Divest Plastics Business
- The Wall Street Journal Interactive Edition
-
Sanofi Wins Approval For New Insulin Drug
- The Wall Street Journal Interactive Edition
-
- The Wall Street Journal Interactive Edition
-
- The Wall Street Journal Interactive Edition
-
Bond Investors Get Set for Megadeals
- The Wall Street Journal Interactive Edition
-
Pharma Grows Itself a New Challenge -- Overheard
- The Wall Street Journal Interactive Edition
-
Merck to Continue Focus on Cancer Drug Keytruda
- The Wall Street Journal Interactive Edition
-
China Approves Syngenta Biotech Corn
- The Wall Street Journal Interactive Edition
-
Biotech Seed Makers Try to Defuse Trade Uncertainties
- The Wall Street Journal Interactive Edition
-
Merck to Buy Cubist for $8.4 Billion
- The Wall Street Journal Interactive Edition
-
Ackman Takes Stake in Animal-Health Company
- The Wall Street Journal Interactive Edition
-
- The Wall Street Journal Interactive Edition
-
Bayer Raises Earnings Forecast
- The Wall Street Journal Interactive Edition
-
Bayer to Buy Assets From DuPont
- The Wall Street Journal Interactive Edition
-
German Drug Firms Target China
- The Wall Street Journal Interactive Edition
-
Germany Bets on ‘Smart Factories’
- The Wall Street Journal Interactive Edition
-
The Race Is On to Find Organic Pesticides
- The Wall Street Journal Interactive Edition
-
Developers Seek to Fill N.J. Office Campuses
- The Wall Street Journal Interactive Edition
- Loading more headlines...
Press Releases on BAYN
No News currently available for BAYN
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com